Can Myopia Be Reversed? - A Study on the Role of Atropine Eye drops in Arresting Myopia Progression

  • Anchal Tripathi Dr
  • RC Gupta LLRM Medical college
  • shalini
Keywords: atropine, axial length, myopia, spherical equivalent

Abstract

Purpose: 

  1. To investigate the effect of atropine in retarding progression of myopia.
  2. To compare rates of retardation of myopia progression using 0.05% atropine and 0.1% atropine.

 

Methods:

This is a hospital based prospective study. Patients were selected from children, between 6-18 yrs of age, visiting the outpatient department of our hospital, with spherical equivalent (SE) =>-1D in both the eyes (with spherical equivalent (SE) progression rate >= 0.5D/year). Groups with 0.05% atropine eyedrops, 0.1% atropine eyedrops and control were allocated randomly. Myopia progression was measured by change in spherical equivalent and axial length at baseline and every 3 months till 1 year.

 

Results: 

In our study, a total of 48 eyes of 24 children were included, out of which 83.33% were in age group 6-12years; rest in 13-18years age group. The mean change in spherical equivalent in our study after one year was -0.72±0.21D, -0.11±0.096D and -0.19±0.18D in placebo, 0.1% and 0.05% atropine groups respectively. Also, the mean change in axial length our study after one year was 0.45±0.15mm, 0.13±0.20mm and 0.11±0.02mm in placebo, 0.1% and 0.05% atropine groups respectively. Change in both parameters were found to be statistically significant.

Conclusion:

We conclude that night time  application of 0.05% and 0.1% atropine eyedrops  is efficacious in retarding progressive myopia in Indian eyes. Atropine eyedrops were better tolerated in pre-adolescent children. Drop out rate was more in the adolescent population, which may be due to more amount of near work.

KEYWORDS: atropine, axial length, myopia, spherical equivalent

Downloads

Download data is not yet available.

References

1. Morgan IG, Ohno- Matsui K, Saw SM. Myopia. Lancet. 2012; 379(9827) : 1739-1748.
2. Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt. 2012; 32(1): 3-16.
3. Sun J, Zhou J, Zhao P, Lian J, Zhu H, Zhou Y et al. High prevalence of myopia in 5060 Chinese University students in Shanghai. Invest Ophthalmol Vis Sci. 2012; 53(12): 7504-7509.
4. Williams KM, Bertelsen G, Cumberland P, Wolfram C, Verhoeven VJ, Anastasopoulos E et al. Increasing prevalence of myopia in Europe and the impact of education. Ophthalmol. 2002; 109(4): 704-711.
5. Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmol. 2002; 109(4): 704-711.
6. Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev 2011; (12): CD004916.
7. Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y et al. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. 2015; 10(4): e0124535.
8. Gwiazda J. Treatment options for myopia. Optom Vis Sci. 2009; 86(6): 624-628.
9. Donders F. On the Anomalies of accommodation and refraction of the eye. London: The New Sydenham Society; 1864.
10. Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et  al. Atropine for the treatment of childhood myopia: safety and  efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the  Treatment of Myopia 2). Ophthalmol. 2012;119(2):347-54.
11. Saw SM, Shih-Yeh EC, Koh A, Tan D. Interventions to retard myopia progression in children: an evidence-based update. Ophthalmol. 2002;109:415-21.
12. Prepas SB. Light, literacy and the absence of ultraviolet radi-ation in the development of myopia. Med Hypotheses. 2008;70:635–7.
13. Kothari M, Rathod V. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes. Indian J Ophthalmol. 2017;65:1178-81.
14. Salazar M, Shimada K, Patil PN. Iris pigmentation and atropine mydriasis. J Pharmacol Exp Ther. 1976;197:79-88.
15. Anderson HA, Bertrand KC, Manny RE, Hu YS, Fern KD. Comparison of two drug combinations for dilating dark irides. Optom Vis Sci. 2010;87:120-4. 
How to Cite
Tripathi, A., Gupta, R. C., & Mohan, S. (2022). Can Myopia Be Reversed? - A Study on the Role of Atropine Eye drops in Arresting Myopia Progression. Tropical Journal of Ophthalmology and Otolaryngology, 6(6), 114-120. Retrieved from https://opthalmology.medresearch.in/index.php/jooo/article/view/217
Section
Original Article